| Literature DB >> 29729787 |
Amanda M Brandow1, Michael R DeBaun2.
Abstract
Sickle cell disease pain manifests as severe acute pain episodes and a debilitating chronic pain syndrome. Acute pain episodes are the most common reason for health care use; however, acute pain episodes are also frequently managed at home. Chronic pain syndrome develops in 30% to 40% of individuals with sickle cell disease, with an increasing incidence and severity with age. We review the critical aspects of pain management that are integral to the comprehensive approach to sickle cell disease pain and are rooted in the biopsychosocial model. The review focuses on opioid pharmacology and psychosocial comorbidities.Entities:
Keywords: Acute pain; Anxiety; Chronic pain syndrome; Depression; Opioids; Sickle cell disease; Sleep
Mesh:
Year: 2018 PMID: 29729787 PMCID: PMC6800257 DOI: 10.1016/j.hoc.2018.01.014
Source DB: PubMed Journal: Hematol Oncol Clin North Am ISSN: 0889-8588 Impact factor: 3.722